Report cover image

Global Angiotensin II Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 174 Pages
SKU # APRC20552663

Description

Summary

According to APO Research, The global Angiotensin II Receptor market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Angiotensin II Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Angiotensin II Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Angiotensin II Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Angiotensin II Receptor is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Angiotensin II Receptor include CJ HealthCare Corp, MorphoSys AG, Vicore Pharma AB and Novartis AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Angiotensin II Receptor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Angiotensin II Receptor, also provides the sales of main regions and countries. Of the upcoming market potential for Angiotensin II Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Angiotensin II Receptor sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Angiotensin II Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Angiotensin II Receptor sales, projected growth trends, production technology, application and end-user industry.

Angiotensin II Receptor Segment by Company

CJ HealthCare Corp
MorphoSys AG
Vicore Pharma AB
Novartis AG
Angiotensin II Receptor Segment by Type

MOR-107
KDT-501
EMA-401
C-21
Others
Angiotensin II Receptor Segment by Application

Women's Health
Immunology
Acute Ischemic Stroke
Respiratory
Others
Angiotensin II Receptor Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Angiotensin II Receptor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Angiotensin II Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Angiotensin II Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Angiotensin II Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

174 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Angiotensin II Receptor Market Size, 2020 VS 2024 VS 2031
1.3 Global Angiotensin II Receptor Market Size Estimates and Forecasts (2020-2031)
1.4 Global Angiotensin II Receptor Sales Estimates and Forecasts (2020-2031)
1.5 Global Angiotensin II Receptor Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Angiotensin II Receptor Market Dynamics
2.1 Angiotensin II Receptor Industry Trends
2.2 Angiotensin II Receptor Industry Drivers
2.3 Angiotensin II Receptor Industry Opportunities and Challenges
2.4 Angiotensin II Receptor Industry Restraints
3 Angiotensin II Receptor Market by Manufacturers
3.1 Global Angiotensin II Receptor Revenue by Manufacturers (2020-2025)
3.2 Global Angiotensin II Receptor Sales by Manufacturers (2020-2025)
3.3 Global Angiotensin II Receptor Average Sales Price by Manufacturers (2020-2025)
3.4 Global Angiotensin II Receptor Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Angiotensin II Receptor Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Angiotensin II Receptor Manufacturers, Product Type & Application
3.7 Global Angiotensin II Receptor Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Angiotensin II Receptor Market CR5 and HHI
3.8.2 Global Top 5 and 10 Angiotensin II Receptor Players Market Share by Revenue in 2024
3.8.3 2024 Angiotensin II Receptor Tier 1, Tier 2, and Tier 3
4 Angiotensin II Receptor Market by Type
4.1 Angiotensin II Receptor Type Introduction
4.1.1 MOR-107
4.1.2 KDT-501
4.1.3 EMA-401
4.1.4 C-21
4.1.5 Others
4.2 Global Angiotensin II Receptor Sales by Type
4.2.1 Global Angiotensin II Receptor Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Angiotensin II Receptor Sales by Type (2020-2031)
4.2.3 Global Angiotensin II Receptor Sales Market Share by Type (2020-2031)
4.3 Global Angiotensin II Receptor Revenue by Type
4.3.1 Global Angiotensin II Receptor Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Angiotensin II Receptor Revenue by Type (2020-2031)
4.3.3 Global Angiotensin II Receptor Revenue Market Share by Type (2020-2031)
5 Angiotensin II Receptor Market by Application
5.1 Angiotensin II Receptor Application Introduction
5.1.1 Women's Health
5.1.2 Immunology
5.1.3 Acute Ischemic Stroke
5.1.4 Respiratory
5.1.5 Others
5.2 Global Angiotensin II Receptor Sales by Application
5.2.1 Global Angiotensin II Receptor Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Angiotensin II Receptor Sales by Application (2020-2031)
5.2.3 Global Angiotensin II Receptor Sales Market Share by Application (2020-2031)
5.3 Global Angiotensin II Receptor Revenue by Application
5.3.1 Global Angiotensin II Receptor Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Angiotensin II Receptor Revenue by Application (2020-2031)
5.3.3 Global Angiotensin II Receptor Revenue Market Share by Application (2020-2031)
6 Global Angiotensin II Receptor Sales by Region
6.1 Global Angiotensin II Receptor Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Angiotensin II Receptor Sales by Region (2020-2031)
6.2.1 Global Angiotensin II Receptor Sales by Region (2020-2025)
6.2.2 Global Angiotensin II Receptor Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Angiotensin II Receptor Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Angiotensin II Receptor Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Angiotensin II Receptor Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Angiotensin II Receptor Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Angiotensin II Receptor Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Angiotensin II Receptor Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Angiotensin II Receptor Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Angiotensin II Receptor Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Angiotensin II Receptor Revenue by Region
7.1 Global Angiotensin II Receptor Revenue by Region
7.1.1 Global Angiotensin II Receptor Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Angiotensin II Receptor Revenue by Region (2020-2025)
7.1.3 Global Angiotensin II Receptor Revenue by Region (2026-2031)
7.1.4 Global Angiotensin II Receptor Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Angiotensin II Receptor Revenue (2020-2031)
7.2.2 North America Angiotensin II Receptor Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Angiotensin II Receptor Revenue (2020-2031)
7.3.2 Europe Angiotensin II Receptor Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Angiotensin II Receptor Revenue (2020-2031)
7.4.2 Asia-Pacific Angiotensin II Receptor Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Angiotensin II Receptor Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Angiotensin II Receptor Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 CJ HealthCare Corp
8.1.1 CJ HealthCare Corp Comapny Information
8.1.2 CJ HealthCare Corp Business Overview
8.1.3 CJ HealthCare Corp Angiotensin II Receptor Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 CJ HealthCare Corp Angiotensin II Receptor Product Portfolio
8.1.5 CJ HealthCare Corp Recent Developments
8.2 MorphoSys AG
8.2.1 MorphoSys AG Comapny Information
8.2.2 MorphoSys AG Business Overview
8.2.3 MorphoSys AG Angiotensin II Receptor Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 MorphoSys AG Angiotensin II Receptor Product Portfolio
8.2.5 MorphoSys AG Recent Developments
8.3 Vicore Pharma AB
8.3.1 Vicore Pharma AB Comapny Information
8.3.2 Vicore Pharma AB Business Overview
8.3.3 Vicore Pharma AB Angiotensin II Receptor Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Vicore Pharma AB Angiotensin II Receptor Product Portfolio
8.3.5 Vicore Pharma AB Recent Developments
8.4 Novartis AG
8.4.1 Novartis AG Comapny Information
8.4.2 Novartis AG Business Overview
8.4.3 Novartis AG Angiotensin II Receptor Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Novartis AG Angiotensin II Receptor Product Portfolio
8.4.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Angiotensin II Receptor Value Chain Analysis
9.1.1 Angiotensin II Receptor Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Angiotensin II Receptor Production Mode & Process
9.2 Angiotensin II Receptor Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Angiotensin II Receptor Distributors
9.2.3 Angiotensin II Receptor Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.